Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
The Christie NHS Foundation Trust in Manchester is seeking a Consultant Pharmacist – Haematology to lead haematology pharmacy services, drive innovation in systemic anti-cancer therapy, and provide expert clinical leadership within a multidisciplinary team.
The post holder will deliver direct patient care as a non-medical prescriber with an own clinic caseload and oversee governance of the Intrathecal Chemotherapy Policy, aligning with network services and satellite sites.
The Christie is one of Europe’s leading cancer centres with an international reputation for delivering excellence in cancer care, research, education and innovation. We are seeking an exceptional and visionary pharmacist to join our Haematology team as a Consultant Pharmacist – Haematology.
This newly credentialled senior leadership role offers a unique opportunity to transform the future of pharmaceutical care for patients with haematological malignancies leading and supporting innovation in systemic anti-cancer therapy (SACT), and other novel therapies within the rapidly growing ATMP treatment landscape.
Working as an integral member of the multidisciplinary team, the successful candidate will provide expert clinical leadership, advanced patient care, strategic service development and professional influence across haematology disease group services at the Trust and across the network. The post holder will deliver their own research and contribute to the wider research agenda.
We welcome applications from pharmacists who have commenced, but not yet completed, the Royal Pharmaceutical Society Consultant pharmacist credentialling process and who can demonstrate substantial progress towards approval may be considered for an interim developmental appointment, pending completion of RPS credentialling.
If you are ready to take on a high-impact leadership role, advance haematology pharmacy practice and make a lasting difference to patients, we would be delighted to hear from you.
The postholder will provide strategic leadership for a high-quality professional clinical pharmacy team supporting haematology services, optimising access to medicines and improving the overall patient experience. The post holder will work in collaboration with the haematology disease group, the Trust’s network services division, multidisciplinary clinical and researcher colleagues, and the Trust’s designated commercial and outsourced service providers to develop and deliver an efficient, high quality, professional and well-coordinated service capable of meeting patients’ clinical needs and all statutory, regulatory and NHS commissioning requirements relating to haematology services including services to other disease groups in respect of ATMPs only. The postholder will support service delivery for haematology patients across the Trust network including satellite sites and neighbourhood initiatives.
This will include provision of direct patient care to patients, as a non-medical prescriber with their own clinic caseload in addition to being responsible for the governance oversight of the Trust’s Intrathecal Chemotherapy Policy and register.
Although the pharmacy service is based at The Christie Hospital main the postholder may be required to work at any location across the Greater Manchester and Cheshire Cancer Network. The Trust has a flexible working policy and, subject to service commitments, it may also be possible to support an element of working from home.
The Christie is one of Europe’s leading cancer centres, looking after more than 64,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester & Cheshire, but as a national specialist around 25% patients are referred to us from other parts of the country.
We are the largest radiotherapy provider in the NHS with one in 20 treatments delivered at The Christie. We have up to 15 linear accelerators operating across our network of sites. We operate the largest chemotherapy unit in the UK on our main site and treatments are also provided at 13 other networked sites, and in patients homes. And as a specialist tertiary surgical centre, we focus on rare cancers, complex procedures, and multidisciplinary approaches to cancer surgery, specialising in colorectal, peritoneal, gynaecological, urological and plastic surgery.
We are also an international leader in research, with world first breakthroughs for over 100 years. We have been named by the UK’s National Institute for Health Research (NIHR), as one of the best hospitals providing opportunities for patients to participate in clinical research studies, with more than 800 studies open at any time, caring for over 3,000 patients.